Product Information
CLOMIPRAMINE 25 MG CAPSULE is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.2669 per EA under NDC 27241021001. Its NADAC has been published 241 times since Feb 24, 2021.
FDA first approved this application on Oct 2, 2020.
The High Outlier badge above means this manufacturer's average price in the Clomipramine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241021001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
CLOMIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213897FDA Approved
10/2/2020
On Market Since
12/23/2020
Pharmacological Classes
Price Statistics
The NADAC for CLOMIPRAMINE 25 MG CAPSULE has been published 241 times since Feb 24, 2021, and over the history we have for it it has declined 87.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2669 per EA |
|---|---|
| All-time high | $2.4765 (Jun 16, 2021) |
| All-time low | $0.1913 (Nov 20, 2024) |
| 52-week high | $0.2669 |
| 52-week low | $0.2660 |
| Median price | $0.3812 |
| Average price | $0.6601 |
| Largest weekly change | +59.2% (May 19, 2021) |
| Weeks tracked | 241 |
| Tracking since | Feb 24, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+0.3%
3Y
-39.1%
5Y
-87.7%
All
-87.6%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLOMIPRAMINE 25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLOMIPRAMINE 25 MG CAPSULE, manufactured by Ajanta Pharma USA Inc., is $0.2669 per EA (NDC 27241021001), effective Oct 1, 2025.
How has the price of CLOMIPRAMINE 25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLOMIPRAMINE 25 MG CAPSULE has declined 87.6%. It has been tracked across 241 weekly CMS publications since Feb 24, 2021.
What are the highest and lowest recorded NADAC prices for CLOMIPRAMINE 25 MG CAPSULE?
Since Feb 24, 2021, the NADAC for CLOMIPRAMINE 25 MG CAPSULE has ranged from a low of $0.1913 (Nov 20, 2024) to a high of $2.4765 (Jun 16, 2021), with a median of $0.3812 per EA.
Are there cheaper alternatives to CLOMIPRAMINE 25 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CLOMIPRAMINE 25 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOMIPRAMINE 25 MG CAPSULE?
CLOMIPRAMINE 25 MG CAPSULE (NDC 27241021001) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.